CDK5RAP2
protein-codingCDK5 regulatory subunit associated protein 2
Gene summary
This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
- MCPH3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~191.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0016660
Submitter: ClinGen
Homozygous variants in CDK5RAP2 were first reported individuals with microcephaly in consanguineous family in 2005 (Bond J, et al., PMID: 15793586). Primary microcephaly (OMIM:604804) characterized by a disproportionately small brain and cerebral cortex further characterized by other significant neurological deficits (delayed psychomotor development, moderate learning difficulties, and significant speech delay). Other clinical manifestation as variation were reported: severe sensorineural hearing loss (Pagnamenta et al. (2012), short stature (-6.7 SD), prominent eyes, conical-shaped and widely spaced teeth (Lancaster et al. (2013)). The mechanism of pathogenicity is known to be autosomal recessive loss-of-function. At least nine loss-of-function variants, 3 homozygous and 6 compound heterozygous, have been reported in 6 probands with primary microcephaly, 3 across six publications (PMIDs: 17764569, 15793586, 22887808, 27761245, 23726037, 23995685). This gene-disease relationship is also supported by patient-derived cerebral organoid (PMID: 23995685) and phenotypically compatible mouse model (PMIDs: 20460369). Inducing wildtype CDK5RAP2 expression rescued the developmental abnormality in patient-derived cerebral organoid, which is genetically knock-out for CDK5RAP2 (PMID: 23995685). In summary, CDK5RAP2 is definitively associated with autosomal recessive primary microcephaly, 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This was discussed and approved by the ClinGen Brain Malformations Gene Curation Expert Panel on 01/25/2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0009022
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011488
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0016660
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011488
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011488
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Neurologic
Intervention: Audiologic/Otolaryngologic
Rationale: The condition can involve congenital hearing impairment, and early recognition and treatment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CDK5RAP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018249.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 184 | 2 | 194 | ||
| missense | 1 | 1 | 439 | 63 | 2 | 506 |
| nonsense | 18 | 13 | 31 | |||
| start loss | 1 | 1 | ||||
| frameshift | 21 | 15 | 1 | 37 | ||
| splice donor/acceptor (+/-2bp) | 2 | 14 | 17 | 33 | ||
| Total | 42 | 43 | 466 | 247 | 4 | 802 |
Highest pathogenic variant AF is 0.00009417491
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060719.4 | 38 | MANE Select | |
| Ensembl | ENSP00000343818.4 | 38 | MANE Select | |
| RefSeq | NP_001011649.1 | 37 | Standard | |
| RefSeq | NP_001258968.1 | 35 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Regulation of PLK1 Activity at G2/M Transition
- Recruitment of mitotic centrosome proteins and complexes
- Loss of Nlp from mitotic centrosomes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Centrosome maturation
Biological Process
- G2/M transition of mitotic cell cycle
- establishment of mitotic spindle orientation
- microtubule cytoskeleton organization
- microtubule bundle formation
- chromosome segregation
Molecular Function
- protein binding
- calmodulin binding
- microtubule binding
- tubulin binding
- protein kinase binding
Cellular Component
- pericentriolar material
- spindle pole
- cytoplasm
- Golgi apparatus
- centrosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000349780
- Coding exons
- 38
- Length
- 191302
- Individuals with no LoFs
- 125582
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 165
- Defined
- 125748
- p
- 0.000660
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.370 | 1005 | 973 | 1.03 | 0.0000540 | 12482 |
| Missense (PolyPhen) | 195 | 212.82 | 0.91627 | 2916 | ||
| Synonymous | 0.350 | 370 | 379 | 0.977 | 0.0000211 | 3505 |
| Loss of Function | 4.41 | 54 | 102 | 0.529 | 0.00000533 | 1281 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.00055 | 0.00052 | rare |
| Ashkenazi Jewish | 0.00089 | 0.00089 | rare |
| East Asian | 0.00060 | 0.00060 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00084 | 0.00084 | rare |
| South Asian | 0.00078 | 0.00075 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Potential regulator of CDK5 activity via its interaction with CDK5R1. Negative regulator of centriole disengagement (licensing) which maintains centriole engagement and cohesion. Involved in regulation of mitotic spindle orientation (By similarity). Plays a role in the spindle checkpoint activation by acting as a transcriptional regulator of both BUBR1 and MAD2 promoter. Together with EB1/MAPRE1, may promote microtubule polymerization, bundle formation, growth and dynamics at the plus ends. Regulates centrosomal maturation by recruitment of the gamma-tubulin ring complex (gamma-TuRC) onto centrosomes (PubMed:26485573). In complex with PDE4DIP isoform 13/MMG8/SMYLE, MAPRE1 and AKAP9, contributes to microtubules nucleation and extension from the centrosome to the cell periphery (PubMed:29162697). Required for the recruitment of AKAP9 to centrosomes (PubMed:29162697). Plays a role in neurogenesis (By similarity). {ECO:0000250|UniProtKB:Q8K389, ECO:0000269|PubMed:17959831, ECO:0000269|PubMed:18042621, ECO:0000269|PubMed:19282672, ECO:0000269|PubMed:19553473, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:29162697}.;
- Disease
- DISEASE: Microcephaly 3, primary, autosomal recessive (MCPH3) [MIM:604804]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:15793586}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0847
Intolerance Scores
- LoFtool
- 0.935
- RVIS EVS
- -1.95
- RVIS percentile EVS
- 1.87
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.639
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |